Israel Englander Replimune Group, Inc. Call Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding REPL
# of Institutions
157Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$123 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$113 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$67.9 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$59.4 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$57.6 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $602M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...